/5
0 avis
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT.
Archive ouverte
Edité par CCSD ; Nature Publishing Group -
International audience
Consulter en ligne
Chargement des enrichissements...